Bazeed AY, Day CM, Garg S. Pancreatic cancer: challenges and opportunities in locoregional therapies. Cancers. 2022;14(17):4257.
Article CAS PubMed PubMed Central Google Scholar
Siegel RL, Miller KD, Wagle NS, Jemal A. 2023 Cancer statistics, 2023. CA: a cancer journal for clinicians. 73(1): 17–48.
Zeng S, Pöttler M, Lan B, Grützmann R, Pilarsky C, Yang H. Chemoresistance in pancreatic cancer. Int J Mol Sci. 2019;20(18):4504.
Article CAS PubMed PubMed Central Google Scholar
Al-Daghistani HI, Zein S, Abbas MA. Microbial communities in the dead sea and their potential biotechnological applications. Commun Integrative Biol. 2024;17(1):2369782.
Lafi Z, Alshaer W, Gharaibeh L, Alqudah DA, AlQuaissi B, Bashaireh B, et al. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. PLoS ONE. 2023;18(9):e0291981.
Article CAS PubMed PubMed Central Google Scholar
Alshaer W, Zraikat M, Amer A, Nsairat H, Lafi Z, Alqudah DA, et al. Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma. RSC Adv. 2019;9(53):30976–88.
Article CAS PubMed PubMed Central Google Scholar
Al Obeidli A, Salah HB, Al Murisi M, Sabouni R. Recent advancements in MOFs synthesis and their green applications. Int J Hydrogen Energy. 2022;47(4):2561–93.
Liu X, Wang C, Wang X, Tian C, Shen Y, Zhu M. A dual-targeting Fe3O4@ C/ZnO-DOX-FA nanoplatform with pH-responsive drug release and synergetic chemo-photothermal antitumor in vitro and in vivo. Mater Sci Eng, C. 2021;118:111455.
Ye X, Xiong M, Yuan K, Liu W, Cai X, Yuan Y, et al. Synthesis and characterization of a novel zinc-based metal-organic framework containing benzoic acid: a low-toxicity carrier for drug delivery. Iranian J Pharma Res. 2023. https://doi.org/10.5812/ijpr-136238.
Wang N, Yu C, Xu T, Yao D, Zhu L, Shen Z, et al. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer. J Nanobiotechnol. 2022;20(1):486.
Lafi Z, Alshaer W, Gharaibeh L, Alqudah D, AlQuaissi B, Bashaireh B, et al. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. PLoS ONE. 2023;18:e0291981.
Article CAS PubMed PubMed Central Google Scholar
Al-Azzawi H, Alshaer W, Esawi E, Lafi Z, Abuarqoub D, Zaza R, et al. Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. J Drug Delivery Sci Technol. 2022;69: 103169.
Al-Harbi SA, Almulaiky YQ. Copper-based metal-organic frameworks (BDC-Cu MOFs) as supporters for α-amylase: stability, reusability, and antioxidant potential. Heliyon. 2024;10(6): e28396.
Article CAS PubMed PubMed Central Google Scholar
Shano LB, Karthikeyan S, Kennedy LJ, Chinnathambi S, Pandian GN. MOFs for next-generation cancer therapeutics through a biophysical approach—a review. Front Bioeng Biotechnol. 2024;12:1397804.
Article PubMed PubMed Central Google Scholar
Liu Y, Wu Y, Luo Z, Li M. Designing supramolecular self-assembly nanomaterials as stimuli-responsive drug delivery platforms for cancer therapy. iScience. 2023;26(3):106279.
Article CAS PubMed PubMed Central Google Scholar
Letwaba J, Uyor UO, Mavhungu ML, Achuka NO, Popoola PA. A review on MOFs synthesis and effect of their structural characteristics for hydrogen adsorption. RSC Adv. 2024;14(20):14233–53.
Article CAS PubMed PubMed Central Google Scholar
Yusuf VF, Malek NI, Kailasa SK. Review on metal–organic framework classification, synthetic approaches, and influencing factors: applications in energy, drug delivery, and wastewater treatment. ACS Omega. 2022;7(49):44507–31.
Article CAS PubMed PubMed Central Google Scholar
Cun J-E, Fan X, Pan Q, Gao W, Luo K, He B, et al. Copper-based metal–organic frameworks for biomedical applications. Adv Coll Interface Sci. 2022;305: 102686.
Singh N, Thakur A. Applications of copper based metal organic frameworks. Mater Today. 2022;50:1906–11.
Challa M, Chinnam S, Rajanna AM, Nandagudi A, Yallur BC, Adimule V. Adsorption efficacy of functionalized Cu-BDC MOFs tethered 2-mercaptobenzimidazole analogue: a comparative study. Heliyon. 2023;9(2): e13223.
Article CAS PubMed PubMed Central Google Scholar
Du J, Chen G, Yuan X, Yuan J, Li L. Multi-stimuli responsive Cu-MOFs@Keratin drug delivery system for chemodynamic therapy. Front Bioeng Biotechnol. 2023;11:1125348.
Article PubMed PubMed Central Google Scholar
Chen G, Luo J, Cai M, Qin L, Wang Y, Gao L, et al. Investigation of metal-organic framework-5 (MOF-5) as an antitumor drug oridonin sustained release carrier. Molecules. 2019;24(18):3369.
Article CAS PubMed PubMed Central Google Scholar
Rezaeipour Y, Zolghadr E, Alizadeh P, Sadri G, Wujcik EK, Afkhami FA, et al. The anticancer properties of metal-organic frameworks and their heterogeneous nanocomposites. Biomater Adv. 2022;139:213013.
Article CAS PubMed Google Scholar
Bhuyan A, Ahmaruzzaman M. Recent advances in MOF-5-based photocatalysts for efficient degradation of toxic organic dyes in aqueous medium. Next Sustain. 2024;3:100016.
Alneghery LM, Al-Zharani M, Nasr FA, Eldin ZE, Al Hujran TA, Tawfeek HM, et al. Fabrication and optimization of naringin-loaded MOF-5 encapsulated by liponiosomes as smart drug delivery, cytotoxicity, and apoptotic on breast cancer cells. Drug Dev Ind Pharm. 2024. https://doi.org/10.1080/03639045.2024.2388786.
Zelenka T, Baláž M, Férová M, Diko P, Bednarčík J, Királyová A, et al. The influence of HKUST-1 and MOF-76 hand grinding/mechanical activation on stability, particle size, textural properties and carbon dioxide sorption. Sci Rep. 2024;14(1):15386.
Article CAS PubMed PubMed Central Google Scholar
Shen J, Zhou W, Jia M, Yang X, Lin J, An L, et al. Tumor Microenvironment-responsive reagent DFS@HKUST-1 for photoacoustic imaging-guided multimethod therapy. ACS Appl Bio Mater. 2021;4(7):5753–64.
Article CAS PubMed Google Scholar
Boroushaki T, Koli MG, Malekshah RE, Dekamin MG. Elucidating anticancer drugs release from UiO-66 as a carrier through the computational approaches. RSC Adv. 2023;13(45):31897–907.
Article CAS PubMed PubMed Central Google Scholar
Kebede Gurmessa B, Taddesse AM, Teju E. UiO-66 (Zr-MOF): Synthesis, characterization, and application for the removal of malathion and 2, 4-D from aqueous solution. Environ Pollut Bioavailab. 2023;35(1):2222910.
Roshanfekr Rad L, Faramarzi H, Anbia M, Irani M. Adsorption of doxorubicin and 5-Fluorouracil anticancer drugs from aqueous media using MIL-101-NH2 (Co/Fe) bi-metal–organic framework. Sep Purif Technol. 2024;339:126597.
Wang J, Chen D, Li B, He J, Duan D, Shao D, et al. Fe-MIL-101 exhibits selective cytotoxicity and inhibition of angiogenesis in ovarian cancer cells via downregulation of MMP. Sci Rep. 2016;6(1):26126.
Article CAS PubMed PubMed Central Google Scholar
Karimi Alavijeh R, Akhbari K. Biocompatible MIL-101(Fe) as a smart carrier with high loading potential and sustained release of curcumin. Inorg Chem. 2020;59(6):3570–8.
留言 (0)